Cross-resistance to polyene and azole drugs in Cryptococcus neoformans.
作者信息
Joseph-Horne T, Hollomon D, Loeffler R S, Kelly S L
机构信息
Krebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, University of Sheffield, United Kingdom.
出版信息
Antimicrob Agents Chemother. 1995 Jul;39(7):1526-9. doi: 10.1128/AAC.39.7.1526.
Abstract
Fluconazole was observed to inhibit sterol 14 alpha-demethylase in the human pathogen Cryptococcus neoformans, and accumulation of a ketosteroid product was associated with growth arrest. A novel mechanism(s) of azole and amphotericin B cross-resistance was identified, unrelated to changes in sterol biosynthesis, as previously identified in Saccharomyces cerevisiae. Reduced cellular content of drug could account for the resistance phenotype, indicating the possible involvement of a mechanism similar to multidrug resistance observed in higher eukaryotes.
摘要
相似文献
1
Cross-resistance to polyene and azole drugs in Cryptococcus neoformans.
Antimicrob Agents Chemother. 1995 Jul;39(7):1526-9. doi: 10.1128/AAC.39.7.1526.
2
Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis.
J Med Vet Mycol. 1996 Jun-Jul;34(3):223-5.
3
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans.
Antimicrob Agents Chemother. 2000 Apr;44(4):1108-11. doi: 10.1128/AAC.44.4.1108-1111.2000.
4
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
Antimicrob Agents Chemother. 1997 Apr;41(4):748-51. doi: 10.1128/AAC.41.4.748.
5
Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
J Antimicrob Chemother. 2015 May;70(5):1396-407. doi: 10.1093/jac/dku554. Epub 2015 Jan 27.
6
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.
Antimicrob Agents Chemother. 1995 Sep;39(9):1934-7. doi: 10.1128/AAC.39.9.1934.
7
Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
PLoS One. 2019 Dec 4;14(12):e0225701. doi: 10.1371/journal.pone.0225701. eCollection 2019.
8
Antifungal drug resistance in pathogenic fungi.
Med Mycol. 1998;36 Suppl 1:119-28.
9
In vivo and in vitro antifungal activity of the polyene derivative SPA-S-753 against encapsulated form of Cryptococcus neoformans.
Infection. 1997 Jan-Feb;25(1):27-31. doi: 10.1007/BF02113503.
10
Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole.
Med Mycol. 2017 Nov 1;55(8):877-882. doi: 10.1093/mmy/myw101.
引用本文的文献
1
Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the species complex.
mBio. 2024 Aug 14;15(8):e0166124. doi: 10.1128/mbio.01661-24. Epub 2024 Jul 9.
2
Pleiotropic roles of LAMMER kinase, Lkh1 in stress responses and virulence of .
Front Cell Infect Microbiol. 2024 May 7;14:1369301. doi: 10.3389/fcimb.2024.1369301. eCollection 2024.
3
Antifungal Resistance in Cryptococcal Infections.
Pathogens. 2024 Jan 29;13(2):128. doi: 10.3390/pathogens13020128.
4
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
J Antimicrob Chemother. 2022 Jul 28;77(8):2053-2073. doi: 10.1093/jac/dkac161.
5
Amphotericin B and Other Polyenes-Discovery, Clinical Use, Mode of Action and Drug Resistance.
J Fungi (Basel). 2020 Nov 27;6(4):321. doi: 10.3390/jof6040321.
6
Widespread amphotericin B-resistant strains of in Hamilton, Canada.
Infect Drug Resist. 2018 Sep 20;11:1549-1555. doi: 10.2147/IDR.S170952. eCollection 2018.
7
Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine Cryptococcosis.
PLoS One. 2014 Nov 13;9(11):e112669. doi: 10.1371/journal.pone.0112669. eCollection 2014.
8
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906. doi: 10.1128/AAC.01115-12. Epub 2012 Sep 4.
9
Regulatory circuitry governing fungal development, drug resistance, and disease.
Microbiol Mol Biol Rev. 2011 Jun;75(2):213-67. doi: 10.1128/MMBR.00045-10.
10
Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Antimicrob Agents Chemother. 2009 Jul;53(7):2804-15. doi: 10.1128/AAC.00295-09. Epub 2009 May 4.
本文引用的文献
1
The structural requirements of sterols for membrane function in Saccharomyces cerevisiae.
Arch Biochem Biophys. 1993 Feb 1;300(2):724-33. doi: 10.1006/abbi.1993.1100.
2
Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans.
Antimicrob Agents Chemother. 1993 Oct;37(10):2101-5. doi: 10.1128/AAC.37.10.2101.
3
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Lancet. 1993 Mar 6;341(8845):595-6. doi: 10.1016/0140-6736(93)90354-j.
4
Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient.
FEMS Microbiol Lett. 1994 Sep 15;122(1-2):39-42. doi: 10.1111/j.1574-6968.1994.tb07140.x.
5
Requirement for a second sterol biosynthetic mutation for viability of a sterol C-14 demethylation defect in Saccharomyces cerevisiae.
J Bacteriol. 1983 Jul;155(1):64-8. doi: 10.1128/jb.155.1.64-68.1983.
6
Nystatin-resistant mutants of yeast: alterations in sterol content.
J Bacteriol. 1971 Oct;108(1):69-73. doi: 10.1128/jb.108.1.69-73.1971.
7
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.
Ann Intern Med. 1986 Feb;104(2):234-40. doi: 10.7326/0003-4819-104-2-234.
8
Multiple functions for sterols in Saccharomyces cerevisiae.
Biochim Biophys Acta. 1985 Dec 4;837(3):336-43. doi: 10.1016/0005-2760(85)90057-8.
9
Amphotericin B-induced oxidative damage and killing of Candida albicans.
J Infect Dis. 1986 Jul;154(1):76-83. doi: 10.1093/infdis/154.1.76.
10
Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae.
J Med Vet Mycol. 1988 Jun;26(3):153-62. doi: 10.1080/02681218880000231.
Zotero 插件